Cardiol Therapeutics Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/ACardiol Therapeutics Inc.CRDLSep 23

   Ownership stake disclosure by Tejara Capital Ltd (amended)

   Tejara Capital Ltd, filed by

2. ROUTINE6-KCardiol Therapeutics Inc.CRDLSep 23

   Foreign issuer report

3. ROUTINESUPPLCardiol Therapeutics Inc.CRDLSep 16

   SUPPL filing

4. ROUTINEF-10/ACardiol Therapeutics Inc.CRDLSep 16

   F-10 filing (amended)

5. ROUTINE6-KCardiol Therapeutics Inc.CRDLSep 16

   Foreign issuer report

6. ROUTINE6-KCardiol Therapeutics Inc.CRDLSep 11

   Foreign issuer report

7. ROUTINE6-KCardiol Therapeutics Inc.CRDLSep 10

   Foreign issuer report

8. ROUTINEF-XCardiol Therapeutics Inc.CRDLSep 10

   F-X filing

9. ROUTINEF-10Cardiol Therapeutics Inc.CRDLSep 10

   F-10 filing

10. ROUTINE6-KCardiol Therapeutics Inc.CRDLSep 9

    Foreign issuer report

11. ROUTINESCHEDULE 13G/ACardiol Therapeutics Inc.CRDLAug 14

    Ownership stake disclosure by MMCAP International Inc. SPC (amended)

    MMCAP International Inc. SPC, filed by

12. ROUTINE6-KCardiol Therapeutics Inc.CRDLAug 12

    Foreign issuer report

13. ROUTINE6-KCardiol Therapeutics Inc.CRDLAug 6

    Foreign issuer report

14. ROUTINE6-KCardiol Therapeutics Inc.CRDLJul 14

    Foreign issuer report

15. ROUTINE6-KCardiol Therapeutics Inc.CRDLJul 9

    Foreign issuer report

16. ROUTINE6-KCardiol Therapeutics Inc.CRDLJun 25

    Foreign issuer report

17. ROUTINE6-KCardiol Therapeutics Inc.CRDLJun 23

    Foreign issuer report

18. ROUTINE6-KCardiol Therapeutics Inc.CRDLMay 26

    Foreign issuer report

19. ROUTINESCHEDULE 13G/ACardiol Therapeutics Inc.CRDLMay 15

    Ownership stake disclosure by MMCAP International Inc. SPC (amended)

    MMCAP International Inc. SPC, filed by

20. ROUTINE6-KCardiol Therapeutics Inc.CRDLMay 14

    Foreign issuer report

21. ROUTINE6-KCardiol Therapeutics Inc.CRDLMay 11

    Foreign issuer report

22. ROUTINE6-KCardiol Therapeutics Inc.CRDLMay 7

    Foreign issuer report

23. ROUTINE6-KCardiol Therapeutics Inc.CRDLApr 28

    Foreign issuer report

24. ROUTINE6-KCardiol Therapeutics Inc.CRDLApr 14

    Foreign issuer report

25. ROUTINE6-KCardiol Therapeutics Inc.CRDLApr 10

    Foreign issuer report

26. ROUTINE6-KCardiol Therapeutics Inc.CRDLApr 1

    Foreign issuer report

27. NOTABLE40-FCardiol Therapeutics Inc.CRDLMar 31

    Annual report

28. ROUTINE6-KCardiol Therapeutics Inc.CRDLFeb 25

    Foreign issuer report

29. ROUTINE6-KCardiol Therapeutics Inc.CRDLFeb 10

    Foreign issuer report

30. ROUTINE6-KCardiol Therapeutics Inc.CRDLFeb 2

    Foreign issuer report

31. ROUTINESCHEDULE 13GCardiol Therapeutics Inc.CRDLJan 30

    Ownership stake disclosure by MMCAP International Inc. SPC

    MMCAP International Inc. SPC, filed by

32. ROUTINE6-KCardiol Therapeutics Inc.CRDLJan 26

    Foreign issuer report

33. ROUTINE6-KCardiol Therapeutics Inc.CRDLJan 23

    Foreign issuer report

34. ROUTINE6-KCardiol Therapeutics Inc.CRDLJan 16

    Foreign issuer report

35. ROUTINE6-KCardiol Therapeutics Inc.CRDLJan 13

    Foreign issuer report

36. ROUTINE6-KCardiol Therapeutics Inc.CRDLDec 1, 2025

    Foreign issuer report

37. ROUTINE6-KCardiol Therapeutics Inc.CRDLNov 13, 2025

    Cardiol Therapeutics Inc. (CRDL) filed a Form 6-K to report on the positive results from its Phase II clinical trial evaluating the safety and efficacy of its lead product candidate for the treatment of acute myocardial infarction.

38. ROUTINE6-KCardiol Therapeutics Inc.CRDLNov 13, 2025

    Foreign issuer report

39. ROUTINESUPPLCardiol Therapeutics Inc.CRDLNov 5, 2025

    SUPPL filing

40. ROUTINEF-XCardiol Therapeutics Inc.CRDLNov 5, 2025

    F-X filing

41. ROUTINEF-10Cardiol Therapeutics Inc.CRDLNov 5, 2025

    F-10 filing

42. ROUTINE6-KCardiol Therapeutics Inc.CRDLNov 5, 2025

    Foreign issuer report

43. ROUTINEDCardiol Therapeutics Inc.CRDLNov 4, 2025

    Private placement notice

Older filings on EDGAR